Professional Documents
Culture Documents
Most inhibitors are highly toxic, and it is essential that they are used strictly in accordance with all relevant safety instructions and procedures.
inhibitor
Molecular mass
Effect
Cycloheximide (3-[2-{3,5-dimethyl- 281.4 2-oxocyclohexyl}-2hyd roxyethyi]glutarimide Puromycin (3'-[a-amino-pmethoxycinnamamido]-3'-dec)xyN, N-dimethyladenosine Castanospermine (8~13indolizidin e- 1(x,613,7(x,81[3-tetrol) 1-Deoxymannojirimycin (1,5dideoxy-1,5-imino-D-mannitol) 1-Deoxynojirimycin (1,5-dideoxy1,5-imino-D-glucitol) Monensin 544.4
Inhibitor of eukaryotic protein synthesis at translational level; used to induce high levels of mRNA prior to removal Protein synthesis inhibitor, Disrupts polyribosomes Inhibits processing of highmannose oligosccharides to complex-type inhibits processing of highmannose oligosaccharides to complex-type Inhibits formation of highmannose oligosaccharides Monovalent ionophore: Multiple effects on glycosylation due to disruption of passage through the Golgi Inhibits processing of highmannose oligosaccharides Prevents N-linked glycosylation
100--360 ~M
200 ~M
189.2
530-1320 ~M
199.6
1000-4000 ~I,M
163.2 692.9
Actinomycin D
Irreversible inhibitor of transcription 0.4-8 IJM from double-standard DNA (RNA synthesis is inhibited at lower concentrations than is DNA synthesis)
Copyright 9 1996 Academic Press Ltd All rights of reproduction in any form reserved
Inhibitor
Molecular mass
Effect
Aphidicolin
338.5
Reversible inhibitor of eukaryotic 3-20 ~tM DNA polymerases cc and t3 and some viral DNA polymerases. May be used to synchronize cell growth Inhibits some viral DNA polymerases (notably in herpesviruses, where it is used to assay DNA synthesis-dependent protein synthesis) Inhibits RNA polymerases II (mRNA) and III (tRNA) 2140 #M
Phosphonoacetic acid
140.0
(z-Amanitin
919.0
0.001-0.01 I~M
Cordycepin (3'-deoxyadenosine)
,...., m . .
251.2
..|..|..
This table is derived from Virology Labfax, D.R. Harper (Ed.), 1993, Bios Scientific Publishers, and is presented here with permission of the publishers.
364
Appendix B